diabetes mellitus
Conditions
Interventions
SMBG machine and lancet device currently prescribed / Accu-chek mobile
Sponsors
Saitama Medical Center, Saitama Medical University Roche Diagnostics Japan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients with diabetes mellitus and receiving insulin or GLP-1 receptor agonist treatment under SMBG (self-monitoring of blood glucose)
Exclusion criteria
Exclusion criteria: patients who don't agree to this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Evaluation on manipulation of SMBG devices (needle and monitor), 2) Impact on psychological and physical stress, comparing SMBG devices currently in use | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Function of SMBG devices that would be found from the point of medical providers 2) Discrepancy of needs of patients and medical providers 3) Evaluation of Accu-chek mobile by medical providers 4) Possibility of lowering efforts by medical providers | — |
Countries
Japan
Contacts
Public ContactMasafumi Matsuda
Saitama Medical Center, Saitama Medical University Depertment of Endocrinology and Diaebtes
Outcome results
None listed